期刊文献+

曲美他嗪对慢性心力衰竭心功能的影响分析 被引量:5

原文传递
导出
摘要 目的观察曲美他嗪对慢性心力衰竭患者心功能的影响。方法选择慢性心力衰竭患者82例,随机分为对照组41例给予常规抗心力衰竭治疗,治疗组41例在常规抗心力衰竭治疗基础上加用曲美他嗪,比较两组疗效。结果曲美他嗪治疗组治疗6个月后超声心动图检测指标明显改善。各观察指标治疗组与对照组比较差异均有统计学意义(P<0.05)。结论曲美他嗪联合常规慢性心力衰竭治疗改善心脏功能有明显疗效。
作者 沈学然 李华
出处 《中国误诊学杂志》 CAS 2010年第18期4316-4316,共1页 Chinese Journal of Misdiagnostics
  • 相关文献

参考文献4

二级参考文献12

  • 1McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet, 1998, 351 :9-13.
  • 2Shirakami G, Nakao K, Yamada T,et al. Inhihitory effect of brain natriuretic peptide ca central angiotensin Ⅱ-stimulated pressor response in conscious rats. Neurosci Lett,1988,91:77-83.
  • 3Zeldel ML. Hormonal regulation of inner medullary collecting duct sodium transport. Am J Physiol, 1993, 265 (2 Pt2) :F159-173.
  • 4Atarashi K, Mulrow PJ, Franco-Saenz R. Effect of atrial peptides on aldosterone production. J Clin Invest, 1985,76:1807-1811.
  • 5Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med. 1998.339:321-328.
  • 6Berger R, Huelsmann M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure-A selection mode for ICD implantation. J Am Coil Cardiol, 2002, 39(suppl B) : 193B.
  • 7Anand I, Latini R, Masson S, et al. The predictive value of combinations of different levels of BNP and NE in the val-HeT trial.J Am Coll Cardiol. 2002,39 (suvvl B) : 406B.
  • 8Hall C, Rouleau JL, Moye L, et al. N-terminal proatrial natriuretic factor. An independent predictor of long-term prognosis after myocardial infarction.Circulation,1994,89:1934-1942.
  • 9Neubauer S.The failing heart-An engine out of fuel[].The New England Journal of Medicine.2007
  • 10Pocock,S.J.,Wang,D.,Pfeffer,M.A.Predictors of mortality and morbidity in patients with chronic heart failure[].European Heart Journal.2006

共引文献117

同被引文献20

  • 1余兆新,杨沙宁,杨学新,彭水先,肖磊,李凤翥.短期曲美他嗪治疗对扩张型心肌病室性心律失常的影响[J].中国民康医学,2004,16(9):539-540. 被引量:4
  • 2赵文方,杨海燕,王庆淑.曲美他嗪治疗慢性心力衰竭[J].中华当代医学,2005,3(2):49-49. 被引量:1
  • 3Hasegawa K,Iwaikanai E,Sasayama S.Neurohormonal regulation of myocardial cell apoptosis during the degulation of heart failure.J cell physiol,2001,186(1):11-18.
  • 4Kantor PF,LacienA,Kozak R,et al.The antinginal drugtrimetazidine shifts cardiac energy metablism from fatty acid exidation to glucose oxidation by inhibitiny mitochondral long chainketcacylcoenzyme a thiolase.Circ Res,2000,86(2):580.
  • 5Wolff AA,Rotmensch HH,Stanley WC,et al.Meabolic approaches to the treatment of ischemic heart disease:the clinicians,perspective.Heart Fail Rev,2002,7(2):187.
  • 6Fundam.Disease:the pharmacology of trimetazidine.Clin Pharmaco,2003,17(2):133.
  • 7dinapoil P,Taccardl AA,Barsotti A.Long term cardioprotective action of trimetazidine and potential effect on the inammatory process in patients with ischemic dilated cardiomyopathy.Heart,2005,91(2):161.
  • 8Bittner V,Weiner D,Yusuts,et al.Predication of mortality and morbidity with 6-minute walk test in patients with left ventricular dysfunction.JAMA,1993,270(5):1702.
  • 9Hasegawa K,lwaikanai E,Sasayama S.Neurohonnonal regulation of myocardial cell apoptosis during the degulation of heart failure.J cell physiol,2001,186(1): 11- 18.
  • 10Kantor PF,LacienA,Kozak R,et al.The antinginal drugtrimetazidine shifts cardiac energy metablism from fatty acid exidation to glucose oxidation by inhibitiny mitochondral long chainketcacylcoenzyme a thiolase[J].Circ P,.es,2000,86(2):580.

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部